Navigation Links
Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
Date:11/29/2007

PHILADELPHIA, Nov. 29 /PRNewswire/ -- As part of an ongoing commitment to help clients reduce product development times and maximize commercial impact of their products, Premier Research Group plc (AIM: PRG) announced today the consolidation of its industry-leading expertise in its core service areas into a single group, Strategic Product Development (SPD).

The expertise within the group closely matches Premier Research's focus on clinical research services in neuroscience, analgesia, oncology, infectious disease, and pediatrics. It also reflects the firm's strength in medical device development, adaptive clinical trials design, and state of the art clinical trial related technologies.

"Client demand is driving this," explained Premier Research Group COO Dr. Troy McCall. "Cost and commercialization pressures have our clients focused on leveraging the insights and expertise gained from the hundreds of studies we conduct each year. We're being asked to become involved earlier and more substantively which is great because it leads to better and more efficient studies."

Dr. McCall added that, "Strategic Product Development, in collaboration with a strong Global Regulatory Affairs capability, reflects the company's deep commitment to being a 'solution provider' for our clients. We're routinely told that this philosophy is an important differentiator for us relative to our competitors, and we've dedicated ourselves to continually building upon this strength."

The group will be led by Samer E. Kaba, MD, Vice President, Global Medical Affairs and SPD and include the following experts:
-- Bernard Brownstein, MD, Vice President, Medical Affairs and SPD --

Pediatrics

-- Luciano Fuccella, MD, Vice President, Medical Affairs and SPD --

Clinical Pharmacology

-- Danielle Giroud, RN, MBA, Vice President, SPD -- Medical Devices

-- Sid Jevons, PhD, Vice President, SPD -- Infectious Diseases

-- Mik
'/>"/>

SOURCE Premier Research Group plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
2. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
3. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
4. IsoTis Receives FDA Clearance for Accell Family of Products
5. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
6. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
9. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
10. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
11. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... CA (PRWEB) August 19, 2014 Robin ... Parkinson’s disease can take on an individual. Symptoms ... decreased facial expression, problems swallowing and severe depression. ... the dying off of dopamine producing neurons of the ... from a disease that slowly and progressively gets worse, ...
(Date:8/19/2014)... , Aug. 19, 2014 ... addition of the "Spectroscopy Equipment and ... report to their offering. ... Spectroscopy Equipment and Accessories in US$ Thousands ... (UV-Vis spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, Near ...
(Date:8/19/2014)... In November 2012, the European Union (EU) mandated use ... a new PSUR – responding to the increasing need to ... drug. Adopted in many regions, the main objectives of the ... and critical analysis of new or emerging information on the ... evidence of the potential benefits of a drug; and , ...
(Date:8/19/2014)... Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" ... reported results of its Oral Amphotericin B (Oral ... The study, conducted by ImmuneCarta®, the immune monitoring ... effectiveness of Oral Amp B in reactivating ... individuals despite intensive treatment with antiretroviral therapy. ...
Breaking Biology Technology:As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3
... Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical ... of post-approval use in the U.S. of XIAFLEX® for ... palpable cord.  After approximately 11,000 injections administered to approximately ... meaningful change in the nature of events expected relative ...
... 2011 Genprex, Inc., formerly known as Convergen ... nanomolecular cancer therapy CNVN202, will be branded as Oncoprex™ ... brand in the oncology sector in recognition of our ... will be used to unlock the unrealized potential of ...
... - QIAGEN assay for JAK2 V617F mutation ... ,JAK2 inhibitor, and to monitor responses to therapy ... exclusive access to JAK2 biomarker underpins potential future expansion with ... QGEN ; Frankfurt, Prime Standard: QIA) today announced that ...
Cached Biology Technology:Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety Update 2Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety Update 3Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety Update 4Genprex Announces New Branding 2QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers 2QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers 3QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers 4
(Date:8/19/2014)... at San Antonio and The University of Texas at ... than $750,000 in grants through the San Antonio Life ... SALSI is a model of how a general academic ... forces for greater research and graduate education. , The ... public health issues and diseases of global impact. Funding ...
(Date:8/19/2014)... August 2014: An engineer at the University of Liverpool ... a brain to communicate with the body. , Dr ... Mahadevan, has developed a mathematical model for earthworms and ... these soft bodied animals get around. , The most ... generator (CPG) which states that the central brain of ...
(Date:8/19/2014)... study that analyzed concentrations of African dust transported ... winter and spring. These research findings offer new ... quality impacts of African dust, including the climate ... occur from increased African dust emissions in the ... (UM) Rosenstiel School of Marine and Atmospheric Science ...
Breaking Biology News(10 mins):San Antonio Life Sciences Institute awards $750,000 to innovators 2San Antonio Life Sciences Institute awards $750,000 to innovators 3Secrets of how worms wriggle uncovered 2Study of African dust transport to South America reveals air quality impacts 2
... , The University of Haifa, Israel, has dedicated Israel,s ... focus on research and development of non-irrigated green roofs; ... and evolutionary theories. The center has been ... expert in the field, and was facilitated by VP ...
... Investigators at Washington University and The Scripps Research Institute ... to facilitate meta-analyses on studies of the metabolism of ... of the Global Metabolomic Initiative was sent to more ... a total of more than 35,000 files of metabolomic ...
... und MÜNCHEN, 7. November 2012 Bausch + Lomb, ... er seine Option zum Kauf aller im Umlauf befindlichen ... GmbH (TPV) ausgeübt hat, einem führenden Hersteller ophthalmologischer Lasersysteme. ... aus einem Joint Venture zwischen Bausch + Lomb und ...
Cached Biology News:Israel's first Green Roofs Ecology research center dedicated at University of Haifa 2Global metabolomic initiative announced 2Global metabolomic initiative announced 3Global metabolomic initiative announced 4Bausch + Lomb übernimmt Technolas Perfect Vision GmbH 2Bausch + Lomb übernimmt Technolas Perfect Vision GmbH 3Bausch + Lomb übernimmt Technolas Perfect Vision GmbH 4
... a serine/threonine phosphatase isolated from human red ... heterodimer of 60kDa (A) and 36kDa (C) ... the a-subunit of phosphorylase kinase. With its ... specificity and may play a regulatory role ...
... Monitoring Kit measures adenosine triphosphate ... and a dynamic range. Based ... assay measures ATP in bacterial, ... a concentration range of 10-11 ...
... Jouan RCT series of refrigerated cold traps ... trapping of low volatility/aqueous solvents or high ... and other vacuum concentrators/centrifugal evaporators. Also used ... systems such as used in electron microscopes. ...
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
Biology Products: